Search research articles
Contact Us
Filters
Showing results (1341-1350 of 1,489) with videos related to
Page
of 149
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 20, 2016
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial
Ralf U Trappe, Daan Dierickx, Heiner Zimmermann, et al.
Human Mutation
|
September 18, 2010
Identification of FOXP1 deletions in three unrelated patients with mental retardation and significant speech and language deficits
Denise Horn, Johannes Kapeller, Núria Rivera-Brugués, et al.
Transplantation
|
May 15, 2018
Immunosuppression Is Associated With Clinical Features and Relapse Risk of B Cell Posttransplant Lymphoproliferative Disorder: A Retrospective Analysis Based on the Prospective, International, Multicenter PTLD-1 Trials
Heiner Zimmermann, Nina Babel, Daan Dierickx, et al.
Human Molecular Genetics
|
March 19, 2026
Association of rare apolipoprotein E ε4 homozygosity with an earlier age at onset in spinocerebellar ataxia type 3
Charlotte Clara Meyer, Eduardo Preusser de Mattos, Rahel Maria Burger, et al.
Molecular Psychiatry
|
July 13, 2000
Allelic distribution of CTG18.1 in Caucasian populations: association studies in bipolar disorder, schizophrenia, and ataxia
M G McInnis, T Swift-Scanlanl, A T Mahoney, et al.
Annals of Neurology
|
December 11, 2007
Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia
Ute Hehr, Peter Bauer, Beate Winner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 23, 2015
A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial
C S Fuchs, S Azevedo, T Okusaka, et al.
Journal of Parkinson'S Disease
|
July 9, 2014
Behavioral deficits and striatal DA signaling in LRRK2 p.G2019S transgenic rats: a multimodal investigation including PET neuroimaging
Matthew D Walker, Mattia Volta, Stefano Cataldi, et al.
European Journal of Human Genetics : EJHG
|
January 27, 2011
Hybridisation-based resequencing of 17 X-linked intellectual disability genes in 135 patients reveals novel mutations in ATRX, SLC6A8 and PQBP1
Lars R Jensen, Wei Chen, Bettina Moser, et al.
Brain : a Journal of Neurology
|
April 18, 2023
Blood transcriptome sequencing identifies biomarkers able to track disease stages in spinocerebellar ataxia type 3
Mafalda Raposo, Jeannette Hübener-Schmid, Ana F Ferreira, et al.
Page
of 149
Search research articles
Search
Showing results (1341-1350 of 1,489) with videos related to
Sort By:
Page
of 149
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 20, 2016
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial
Ralf U Trappe, Daan Dierickx, Heiner Zimmermann, et al.
Human Mutation
|
September 18, 2010
Identification of FOXP1 deletions in three unrelated patients with mental retardation and significant speech and language deficits
Denise Horn, Johannes Kapeller, Núria Rivera-Brugués, et al.
Transplantation
|
May 15, 2018
Immunosuppression Is Associated With Clinical Features and Relapse Risk of B Cell Posttransplant Lymphoproliferative Disorder: A Retrospective Analysis Based on the Prospective, International, Multicenter PTLD-1 Trials
Heiner Zimmermann, Nina Babel, Daan Dierickx, et al.
Human Molecular Genetics
|
March 19, 2026
Association of rare apolipoprotein E ε4 homozygosity with an earlier age at onset in spinocerebellar ataxia type 3
Charlotte Clara Meyer, Eduardo Preusser de Mattos, Rahel Maria Burger, et al.
Molecular Psychiatry
|
July 13, 2000
Allelic distribution of CTG18.1 in Caucasian populations: association studies in bipolar disorder, schizophrenia, and ataxia
M G McInnis, T Swift-Scanlanl, A T Mahoney, et al.
Annals of Neurology
|
December 11, 2007
Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia
Ute Hehr, Peter Bauer, Beate Winner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 23, 2015
A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial
C S Fuchs, S Azevedo, T Okusaka, et al.
Journal of Parkinson'S Disease
|
July 9, 2014
Behavioral deficits and striatal DA signaling in LRRK2 p.G2019S transgenic rats: a multimodal investigation including PET neuroimaging
Matthew D Walker, Mattia Volta, Stefano Cataldi, et al.
European Journal of Human Genetics : EJHG
|
January 27, 2011
Hybridisation-based resequencing of 17 X-linked intellectual disability genes in 135 patients reveals novel mutations in ATRX, SLC6A8 and PQBP1
Lars R Jensen, Wei Chen, Bettina Moser, et al.
Brain : a Journal of Neurology
|
April 18, 2023
Blood transcriptome sequencing identifies biomarkers able to track disease stages in spinocerebellar ataxia type 3
Mafalda Raposo, Jeannette Hübener-Schmid, Ana F Ferreira, et al.
Page
of 149